Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer-Reference-Cited by-同舟云学术

Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer

Published:2015-04-02 Issue:17 Volume:6 Page:15022-15034
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Xiaojun¹²,Song Xiaomeng¹,Yue Wen²,Chen Dongshi²,Yu Jian³,Yao Zhi¹,Zhang Lin²

Affiliation:

1. Department of Immunology, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Immuno Microenvironment and Disease of the Educational Ministry, Tianjin Medical University, Tianjin, P.R. China

2. Department of Pharmacology and Chemical Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

3. Department of Pathology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of pelvic organ prolapse influenced by FBLN5 via FOSL1/miR-222/MEIS1/COL3A1 axis;Cellular Signalling;2024-02

2. FBLN5 as One Presumably Prognostic Gene Potentially Modulating Tumor Immune Microenvironment for Renal Clear Cell Carcinoma in Children and Young Adults;Pharmacogenomics and Personalized Medicine;2024-01

3. Advances in the Study of the Relationship between Fibulin-5 and Tumours;Advances in Clinical Medicine;2024

4. Genetic screening for anticancer genes highlights FBLN5 as a synthetic lethal partner of MYC;Cell Communication and Signaling;2023-10-20

5. Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy;International Journal of Molecular Sciences;2023-09-07